TABLE 2.
Comparison of 50% transforming doses of NeorEBV, EBER(−)EBV, and EBER(+)EBV
| EBV type | TD50/ml
|
||
|---|---|---|---|
| Expt 1 | Expt 2 | Expt 3 | |
| Neor | 104.7 | 105.5 | 105.5 |
| EBER(−) | 102.7 | 103.0 | 103.2 |
| EBER(+) | 104.0 | 104.3 | 104.5 |
Comparison of 50% transforming doses of NeorEBV, EBER(−)EBV, and EBER(+)EBV
| EBV type | TD50/ml
|
||
|---|---|---|---|
| Expt 1 | Expt 2 | Expt 3 | |
| Neor | 104.7 | 105.5 | 105.5 |
| EBER(−) | 102.7 | 103.0 | 103.2 |
| EBER(+) | 104.0 | 104.3 | 104.5 |